Nureca Ltd (NURECA) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 1003462, "name": "Nureca", "stock_name": "Nureca", "full_name": "Nureca Ltd", "name_url": "stocks-analysis/nureca", "exchange": 0, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "318.15", "chg": -12.8, "chgp": "-3.87%", "dir": -1, "prev_price": "330.95", "mcapval": "315.00 Cr", "mcap": "Micro Cap", "scripcode": 543264, "symbol": "NURECA", "ind_name": "Healthcare Services", "ind_code": 26, "sector_id": 35, "indexname": "India SENSEX", "isin": "INE0DSF01015", "curr_date": "Aug 11, 03:30 PM", "curr_time": "19:23 PM", "last_traded_at": "Aug 11, 03:30 PM IST", "bse_nse_vol": "13.18 k", "exc_status": "Active", "traded_date": "Aug 11, 2026", "traded_date_str": "2026 08 11", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-register-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/nureca-1003462-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0 } }, "news": { "results": [ { "title": "Broad-Based Technical Strength Lifts Nureca Ltd to 52-Week High of Rs 348.75", "link": "https://www.marketsmojo.com/news/stocks-in-action/nureca-ltd-hits-new-52-week-high-marking-significant-market-milestone-4140199", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/NurecaLtd_priceRelatedfactors_4140199.png", "date": "2026-08-06 13:41:09", "description": "With a 50.58% gain over the past year, Nureca Ltd has surged well ahead of the Sensex’s modest decline of 2.16%, culminating in a fresh 52-week high of Rs 348.75 on 6 Aug 2026. This milestone caps a sustained rally fuelled by a confluence of bullish technical indicators and robust price momentum." }, { "title": "Nureca Ltd is Rated Sell by MarketsMOJO", "link": "https://www.marketsmojo.com/news/stock-recommendation/nureca-ltd-is-rated-sell-by-marketsmojo-4132358", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/NurecaLtd_mojoScore_4132358.png", "date": "2026-08-02 10:10:16", "description": "Nureca Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 21 July 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 02 August 2026, providing investors with the latest insights into the company’s fundamentals, valuation, financial trends, and technical outlook." }, { "title": "Broad-Based Technical Strength Lifts Nureca Ltd to 52-Week High of Rs 348.75", "link": "https://www.marketsmojo.com/news/stocks-in-action/nureca-ltd-hits-new-52-week-high-of-rs34875-marking-significant-rally-4130523", "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/NurecaLtd_priceRelatedfactors_4130523.png", "date": "2026-07-31 15:11:00", "description": "Surging past its previous peaks, Nureca Ltd touched a fresh 52-week high of Rs 348.75 on 31 Jul 2026, marking a significant milestone in its price momentum. This rally has been underpinned by a confluence of technical indicators aligning favourably, even as the broader market showed modest gains." }, { "title": "Nureca Ltd Gains 7.97%: 3 Key Factors Driving the Weekly Rally", "link": "https://www.marketsmojo.com/news/stocks-in-action/nureca-ltd-gains-797-3-key-factors-driving-the-weekly-rally-4120414", "imagepath": "", "date": "2026-07-25 12:01:33", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>20 Jul:</strong> Stock opens at ₹282.00, modest 1.24% gain amid flat Sensex</p>\n <p><strong>22 Jul:</strong> Strong Q1 FY27 results announced; technical upgrade to Sell rating</p>\n <p><strong>23 Jul:</strong> Valuation concerns surface as stock hits ₹312.05 (+6.85%)</p>\n <p><strong>24 Jul:</strong> Week closes at ₹300.75, up 7.97% for the week versus Sensex decline</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.278.55</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">W..." }, { "title": "Nureca Ltd Valuation Shifts Highlight Price Attractiveness Concerns", "link": "https://www.marketsmojo.com/news/stocks-in-action/nureca-ltd-valuation-shifts-highlight-price-attractiveness-concerns-4116987", "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/NurecaLtd_valuationdot_4116987.png", "date": "2026-07-23 08:02:20", "description": "Nureca Ltd, a micro-cap player in the Healthcare Services sector, has seen a notable shift in its valuation parameters, moving from a risky to an expensive classification. Despite a recent surge in share price, the company’s elevated price-to-earnings (P/E) and price-to-book value (P/BV) ratios raise questions about its price attractiveness relative to historical levels and peer benchmarks." }, { "title": "Nureca Q1 FY27: Strong Turnaround But Profitability Concerns Persist", "link": "https://www.marketsmojo.com/news/result-analysis/nureca-q1-fy27-strong-turnaround-but-profitability-concerns-persist-4115312", "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/Nureca_quaterlyResult_4115312.png", "date": "2026-07-22 09:48:23", "description": "Nureca Ltd., a micro-cap healthcare services company, reported a dramatic turnaround in Q1 FY27 with net profit surging 279.01% year-on-year to ₹3.07 crores, driven by robust revenue growth and improved operational efficiency. The ₹301.81 crore market capitalisation company witnessed its stock rally 8.30% to ₹316.30 following the results announcement, though concerns about heavy reliance on other income and elevated valuations continue to cloud the investment outlook." }, { "title": "Nureca Ltd Upgraded to Sell as Technicals Improve Amid Mixed Financials", "link": "https://www.marketsmojo.com/news/stock-recommendation/nureca-ltd-upgraded-to-sell-as-technicals-improve-amid-mixed-financials-4114668", "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/NurecaLtd_mojoScore_4114668.png", "date": "2026-07-22 08:29:44", "description": "Nureca Ltd, a micro-cap player in the healthcare services sector, has seen its investment rating upgraded from Strong Sell to Sell as of 21 July 2026. This change reflects a nuanced shift in the company’s technical outlook amid persistent fundamental challenges. While the stock has demonstrated notable short-term momentum and positive quarterly financial results, long-term concerns remain over profitability and valuation metrics." }, { "title": "Are Nureca Ltd latest results good or bad?", "link": "https://www.marketsmojo.com/news/result-analysis/are-nureca-ltd-latest-results-good-or-bad-4114085", "imagepath": "", "date": "2026-07-21 19:15:50", "description": "Nureca Ltd's latest financial results for Q4 FY26 reflect significant operational challenges. The company reported a net loss of ₹6.09 crores, marking a stark contrast to the profit of ₹3.73 crores in the previous quarter. This represents a notable decline in profitability, with a quarter-on-quarter change of -263.27%. Additionally, the operating margin fell to -16.29%, the lowest in the last seven quarters, indicating severe margin erosion and operational stress.\n\nOn the revenue front, Nureca achieved ₹35.41 crores, which is an 11.56% increase year-on-year from ₹31.74 crores in Q4 FY25. However, this figure also reflects a sequential decline of 10.67% from ₹39.64 crores in Q3 FY26, breaking the momentum of previous growth. The company's ability to convert this revenue growth into profitability has come under scrutiny, raising concerns about cost management and competitive positioning.\n\nThe return on equity..." }, { "title": "When is the next results date for Nureca Ltd?", "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-nureca-ltd-4104219", "imagepath": "", "date": "2026-07-15 23:16:59", "description": "The next results date for Nureca Ltd is scheduled for July 21, 2026...." } ], "total": 281, "sid": "1003462", "stock_news_url": "https://www.marketsmojo.com/news/nureca-1003462" }, "announcements": [ { "caption": "Pendency Of Litigation(S)/Dispute(S) Or The Outcome Impacting The Company.", "datetime": "07-Aug-2026", "details": "Pendency of Litigation(s)/disput(s) or the outcome impacting the Company.", "source": "BSE" }, { "caption": "Shareholder Meeting / Postal Ballot-Scrutinizers Report", "datetime": "28-Jul-2026", "details": "Scrutinizer Report and Voting Results for the 10th Annual General Meeting", "source": "BSE" }, { "caption": "Shareholder Meeting / Postal Ballot-Outcome of AGM", "datetime": "28-Jul-2026", "details": "Outcome and Proceedings of the 10th Annual General Meeting.", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Nureca Ltd has declared <strong>30%</strong> dividend, ex-date: 24 Feb 22", "dt": "2022-02-24", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

20 Jul: Stock opens at ₹282.00, modest 1.24% gain amid flat Sensex

22 Jul: Strong Q1 FY27 results announced; technical upgrade to Sell rating

23 Jul: Valuation concerns surface as stock hits ₹312.05 (+6.85%)

24 Jul: Week closes at ₹300.75, up 7.97% for the week versus Sensex decline

Week Open

Rs.278.55

W...

Read full news article

Nureca Ltd Valuation Shifts Highlight Price Attractiveness Concerns

2026-07-23 08:02:20

Nureca Ltd, a micro-cap player in the Healthcare Services sector, has seen a notable shift in its valuation parameters, moving from a risky to an expensive classification. Despite a recent surge in share price, the company’s elevated price-to-earnings (P/E) and price-to-book value (P/BV) ratios raise questions about its price attractiveness relative to historical levels and peer benchmarks.

Read full news article

Nureca Q1 FY27: Strong Turnaround But Profitability Concerns Persist

2026-07-22 09:48:23

Nureca Ltd., a micro-cap healthcare services company, reported a dramatic turnaround in Q1 FY27 with net profit surging 279.01% year-on-year to ₹3.07 crores, driven by robust revenue growth and improved operational efficiency. The ₹301.81 crore market capitalisation company witnessed its stock rally 8.30% to ₹316.30 following the results announcement, though concerns about heavy reliance on other income and elevated valuations continue to cloud the investment outlook.

Read full news article

Nureca Ltd Upgraded to Sell as Technicals Improve Amid Mixed Financials

2026-07-22 08:29:44

Nureca Ltd, a micro-cap player in the healthcare services sector, has seen its investment rating upgraded from Strong Sell to Sell as of 21 July 2026. This change reflects a nuanced shift in the company’s technical outlook amid persistent fundamental challenges. While the stock has demonstrated notable short-term momentum and positive quarterly financial results, long-term concerns remain over profitability and valuation metrics.

Read full news article

Are Nureca Ltd latest results good or bad?

2026-07-21 19:15:50

Nureca Ltd's latest financial results for Q4 FY26 reflect significant operational challenges. The company reported a net loss of ₹6.09 crores, marking a stark contrast to the profit of ₹3.73 crores in the previous quarter. This represents a notable decline in profitability, with a quarter-on-quarter change of -263.27%. Additionally, the operating margin fell to -16.29%, the lowest in the last seven quarters, indicating severe margin erosion and operational stress. On the revenue front, Nureca achieved ₹35.41 crores, which is an 11.56% increase year-on-year from ₹31.74 crores in Q4 FY25. However, this figure also reflects a sequential decline of 10.67% from ₹39.64 crores in Q3 FY26, breaking the momentum of previous growth. The company's ability to convert this revenue growth into profitability has come under scrutiny, raising concerns about cost management and competitive positioning. The return on equity...

Read full news article

When is the next results date for Nureca Ltd?

2026-07-15 23:16:59

The next results date for Nureca Ltd is scheduled for July 21, 2026....

Read full news article